Liver Unit, Department of Gastroenterology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
Psychol Med. 2013 Dec;43(12):2603-13. doi: 10.1017/S0033291713000500. Epub 2013 Mar 22.
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of elevated alanine aminotransferase (ALT). NAFLD is associated with insulin resistance and hepatic inflammation. Similarly, patients with depression exhibit insulin resistance and increased inflammatory markers. However, no study has shown a clear association between elevated ALT and the development of depression. The aim of the study was to test whether elevated ALT, a surrogate marker for NAFLD, predicts the development of depression.
The present prospective cohort study investigated 12 180 employed adults referred for health examinations that included fasting blood tests and anthropometric measurements between 2003 and 2010. Exclusion criteria were: baseline minor/major depression, excessive alcohol consumption and other causes for ALT elevation. Depression was evaluated by the eight-item Patient Health Questionnaire (PHQ-8) score.
The final cohort included 5984 subjects [69.4% men, aged 45.0 (s.d. = 10.24) years]. The incidence rate of minor and major depression was 3.8% and 1.4%, respectively. Elevated ALT was a significant independent predictor for the occurrence of minor [odds ratio (OR) 2.02, 95% confidence interval (CI) 1.40-2.92] and major (OR 3.132, 95% CI 1.81-5.40) depression after adjusting for age, gender, body mass index, education level, serum levels of lipids, glucose, smoking and physical activity. Adding subjective health and affective state parameters (sleep disturbances, self-rated health, anxiety and burnout) as potential mediators only slightly ameliorated the association. Persistently elevated ALT was associated with the greatest risk for minor or major depression as compared with elevation only at baseline or follow-up (p for trend < 0.001).
Elevated ALT was associated with developing depressive symptoms, thus suggesting that NAFLD may represent an independent modifiable risk factor for depression.
非酒精性脂肪性肝病(NAFLD)是导致丙氨酸氨基转移酶(ALT)升高的最常见原因。NAFLD 与胰岛素抵抗和肝炎症有关。同样,患有抑郁症的患者表现出胰岛素抵抗和炎症标志物增加。然而,尚无研究表明 ALT 升高与抑郁症的发生之间存在明确关联。本研究旨在测试 ALT 升高(NAFLD 的替代标志物)是否可预测抑郁症的发生。
本前瞻性队列研究调查了 2003 年至 2010 年间进行健康检查的 12180 名在职成年人,这些检查包括空腹血液检查和人体测量。排除标准为:基线轻度/重度抑郁症、过量饮酒和其他导致 ALT 升高的原因。使用 PHQ-8 量表评估抑郁情况。
最终队列纳入 5984 名受试者[69.4%为男性,年龄 45.0(s.d. = 10.24)岁]。轻度和重度抑郁症的发生率分别为 3.8%和 1.4%。校正年龄、性别、体重指数、教育程度、血脂、血糖、吸烟和体力活动水平后,ALT 升高是轻度(比值比[OR] 2.02,95%置信区间[CI] 1.40-2.92)和重度(OR 3.132,95% CI 1.81-5.40)抑郁症发生的独立预测因素。纳入主观健康和情感状态参数(睡眠障碍、自我评估健康、焦虑和倦怠)作为潜在中介因素后,关联略有改善。与仅在基线或随访时升高相比,持续升高的 ALT 与轻度或重度抑郁症的风险最高相关(趋势检验 p<0.001)。
ALT 升高与抑郁症状的发展相关,这表明 NAFLD 可能是抑郁症的一个独立可改变的危险因素。